- Open
- 2.36
- High
- 2.44
- Low
- 2.36
- Close
- 2.38
- Change
- -0.02 (-0.84%)
- Volume
- 197,412
| 5 Nov 2026 | 07:00:01 | Transaction in Own Shares |
| 4 Nov 2026 | 07:00:05 | Transaction in Own Shares |
| 3 Nov 2026 | 07:00:02 | Transaction in Own Shares |
| 2 Nov 2026 | 07:01:00 | Total Voting Rights |
| 24 Apr 2026 | Annual Report and Audited Consolidated Financial Statements | |
| 17 Apr 2025 | Annual Report and Audited Consolidated Financial Statements | |
| 25 Apr 2024 | Annual Report and Accounts |
RTW Biotech Opportunities Ltd invests in the biotechnology and healthcare sectors, focusing on companies that develop pharmacological and medical therapeutic assets. Its geographic focus is global, with an emphasis on identifying growth potential in life sciences. The trust aims for long-term capital appreciation through a diversified portfolio across various therapeutic categories and product types.
| 5 Nov 2026 | 07:00:01 | Transaction in Own Shares |
| 4 Nov 2026 | 07:00:05 | Transaction in Own Shares |
| 3 Nov 2026 | 07:00:02 | Transaction in Own Shares |
| 2 Nov 2026 | 07:01:00 | Total Voting Rights |
| 24 Apr 2026 | Annual Report and Audited Consolidated Financial Statements | |
| 17 Apr 2025 | Annual Report and Audited Consolidated Financial Statements | |
| 25 Apr 2024 | Annual Report and Accounts |
RTW Biotech Opportunities Ltd invests in the biotechnology and healthcare sectors, focusing on companies that develop pharmacological and medical therapeutic assets. Its geographic focus is global, with an emphasis on identifying growth potential in life sciences. The trust aims for long-term capital appreciation through a diversified portfolio across various therapeutic categories and product types.
| 2 Nov 2026 |
| 07:00:06 |
| Transaction in Own Shares |
| 10 Sept 2026 |
| Healthcare funds have roared back, but investors need to know what they’re buying |
| 4 Sept 2026 | Week Ahead: AB Foods, Currys, Dunelm, Fevertree Drinks |
| 19 Aug 2026 | RTW Biotech Opportunities scores again as Biomarin buys Alesta |
| 17 Aug 2026 | Trust round-up: Claverhouse, Riverstone Credit, RIT Cap, & RTW |
| 14 Aug 2026 | RTW Biotech Opportunities outperforms biotech benchmarks in July |
| 12 Aug 2026 | RTW Biotech Opportunities delivers fourth reverse merger of 2026 |
Baroness Blackwood of North Oxford has interests in this issuer
| 2 Nov 2026 |
| 07:00:06 |
| Transaction in Own Shares |
| 10 Sept 2026 |
| Healthcare funds have roared back, but investors need to know what they’re buying |
| 4 Sept 2026 | Week Ahead: AB Foods, Currys, Dunelm, Fevertree Drinks |
| 19 Aug 2026 | RTW Biotech Opportunities scores again as Biomarin buys Alesta |
| 17 Aug 2026 | Trust round-up: Claverhouse, Riverstone Credit, RIT Cap, & RTW |
| 14 Aug 2026 | RTW Biotech Opportunities outperforms biotech benchmarks in July |
| 12 Aug 2026 | RTW Biotech Opportunities delivers fourth reverse merger of 2026 |
Baroness Blackwood of North Oxford has interests in this issuer
| Issuer | Mkt cap | 1Y |
|---|---|---|
| $81.18bn | +0.0% | |
| $2.41bn | +0.2% | |
RTWRTW Biotech Opportunities Ltd | $760m | +0.3% |
| $324m | +0.1% | |
| $76m | +0.2% | |
| $26m | +0.1% |
| Issuer | Mkt cap | 1Y |
|---|---|---|
| $81.18bn | +0.0% | |
| $2.41bn | +0.2% | |
RTWRTW Biotech Opportunities Ltd | $760m | +0.3% |
| $324m | +0.1% | |
| $76m | +0.2% | |
| $26m | +0.1% |